The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail


15 milligram(s) Tablet

Takeda Pharma A/SEU/1/00/151/002

Main Information

Trade NameGlustin
Active SubstancesPioglitazone
Strength15 milligram(s)
Dosage FormTablet
Licence HolderTakeda Pharma A/S
Licence NumberEU/1/00/151/002

Group Information

ATC CodeA10BG Thiazolidinediones
A10BG03 pioglitazone


Licence Issued11/10/2000
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back